Literature DB >> 24681390

6-Amino-2,4,5-trimethylpyridin-3-ols: a new general synthetic route and antiangiogenic activity.

Dong-Guk Kim1, Youra Kang1, Hyunji Lee1, Eun Kyung Lee1, Tae-gyu Nam2, Jung-Ae Kim3, Byeong-Seon Jeong4.   

Abstract

A new synthetic strategy for preparation of a wide range of 6-amino-2,4,5-trimethylpyridin-3-ols from pyridoxine·HCl via a six-step sequence has been developed. This approach features an introduction of various amino groups to C(6)-position of 3-benzyloxy-6-bromo-2,4,5-trimethylpyridine (13), a key intermediate, by a Buchwald-Hartwig amination reaction using palladium(0) transition metal, which certainly renders an expanded scope of amino substituents. Some analogs prepared using the methods described here showed high level of antiangiogenic and antitumor activities in chick chorioallantoic membrane (CAM) assay, demonstrating the potential of these new aminopyridinols as antiangiogenic agents.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aminopyridinol; Angiogenesis; Antiangiogenic; Antitumor; Chick chorioallantoic membrane assay

Mesh:

Substances:

Year:  2014        PMID: 24681390     DOI: 10.1016/j.ejmech.2014.03.045

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

Review 1.  Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology.

Authors:  Jianbo Zhou; Li Wang; Cheng Peng; Fu Peng
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

2.  Synthesis and evaluation of 6-heteroarylamino-2,4,5-trimethylpyridin-3-ols as inhibitors of TNF-α-induced cell adhesion and inflammatory bowel disease.

Authors:  Sang Won Park; Suhrid Banskota; Pallavi Gurung; You Jin Jin; Han-Eol Kang; Chhabi Lal Chaudhary; Sang Yeul Lee; Byeong-Seon Jeong; Jung-Ae Kim; Tae-Gyu Nam
Journal:  Medchemcomm       Date:  2018-06-08       Impact factor: 3.597

3.  Tryptophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling.

Authors:  Jaya Gautam; Suhrid Banskota; Sushil Chandra Regmi; Subi Ahn; Yong Hyun Jeon; Hyunyoung Jeong; Seung Joo Kim; Tae-Gyu Nam; Byeong-Seon Jeong; Jung-Ae Kim
Journal:  Mol Cancer       Date:  2016-11-21       Impact factor: 27.401

4.  BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis.

Authors:  Youra Kang; Maheshwor Timilshina; Tae-Gyu Nam; Byeong-Seon Jeong; Jae-Hoon Chang
Journal:  Biol Res       Date:  2017-02-28       Impact factor: 5.612

5.  Synthesis, activity and mechanism of alkoxy-, carbamato-, sulfonamido-, thioureido-, and ureido-derivatives of 2,4,5-trimethylpyridin-3-ol against inflammatory bowel disease.

Authors:  Chhabi Lal Chaudhary; Pallavi Gurung; Seoul Jang; Suhrid Banskota; Tae-Gyu Nam; Jung-Ae Kim; Byeong-Seon Jeong
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

6.  6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol derivatives as selective fibroblast growth factor receptor 4 inhibitors: design, synthesis, molecular docking, and anti-hepatocellular carcinoma efficacy evaluation.

Authors:  Chhabi Lal Chaudhary; Dongchul Lim; Prakash Chaudhary; Diwakar Guragain; Bhuwan Prasad Awasthi; Hee Dong Park; Jung-Ae Kim; Byeong-Seon Jeong
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

7.  Synthesis of Pyridoxine-Derived Dimethylpyridinols Fused with Aminooxazole, Aminoimidazole, and Aminopyrrole.

Authors:  Bhuwan Prasad Awasthi; Hyunji Lee; Byeong-Seon Jeong
Journal:  Molecules       Date:  2022-03-23       Impact factor: 4.411

8.  BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway.

Authors:  Suhrid Banskota; Jaya Gautam; Sushil C Regmi; Pallavi Gurung; Myo-Hyeon Park; Seung Joo Kim; Tae-Gyu Nam; Byeong-Seon Jeong; Jung-Ae Kim
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

9.  Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation.

Authors:  Suman Acharya; Maheshwor Timilshina; Liyuan Jiang; Sabita Neupane; Dong-Young Choi; Sang Won Park; Sang Yeul Lee; Byeong-Seon Jeong; Jung-Ae Kim; Tae-Gyu Nam; Jae-Hoon Chang
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

10.  Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis.

Authors:  Jaya Gautam; Suhrid Banskota; Hyunji Lee; Yu-Jeong Lee; Yong Hyun Jeon; Jung-Ae Kim; Byeong-Seon Jeong
Journal:  Exp Mol Med       Date:  2018-09-05       Impact factor: 8.718

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.